SS

Saroj Sharma

Active Director Director DIN 07439452
DIN 07439452 First appointment Feb 2016 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2016
Shareholding value •••• Premium profile

About Saroj Sharma

Data last updated:

Saroj Sharma is a Director at Neuperficio Pharma Care Private Limited (since 2016). The company operates in Trading. Neuperficio Pharma Care Private Limited reported revenue of ₹52,231 (FY 2017).

DIN 07439452
Primary Designation Director
Industry Trading
First Appointment 18 Feb 2016
Oldest Company Age 13 yrs
Largest company Neuperficio Pharma Care Private Limited · ₹52,231 (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Feb 20162013₹52,231 (FY 2017)Active

Board colleagues of Saroj Sharma

NameDINCompanyDesignation
Neera Sharma07439464Neuperficio Pharma Care Private LimitedDirector

Directorship timeline

Open interactive timeline →
Neuperficio Pharma Care Private Limited
Premium access

Shareholding and investment profile for Saroj Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saroj Sharma

Saroj Sharma currently holds 1 directorship: Neuperficio Pharma Care Private Limited (Director, since 18 Feb 2016, revenue ₹52,231 (FY 2017)).

Saroj Sharma was first appointed on 18 Feb 2016 as Director at Neuperficio Pharma Care Private Limited.

The current boards of Saroj Sharma's companies include Neera Sharma (Neuperficio Pharma Care Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available